Dopamine deficits and regulation of the cAMP second messenger system in brains of simian immunodeficiency virus–infected rhesus monkeys

References

• Adamson D C, Wildemann B, Sasaki M, Glass J D, McArthur J C, Christov V I, Dawson T M, Dawson V L. 1996; Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41, Science. 274: 1917–1921
   Google Scholar
• Aloisi F, De, Simone R, Columba-Cabezas S, Levi G. 1999; Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities, J Neurosci Res. 56: 571–580
   Google Scholar
• Arendt G, Hefter H, Elsing C, Strohmeyer G, Freund H J. 1990; Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit, J Neurol. 237: 362–368
   Google Scholar
• Aylward E H, Henderer J D, McArthur J C, Brettschneider P D, Harris G J, Barta P E, Pearlson G D. 1993; Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging, Neurology. 43: 2099–2104
   Google Scholar
• Berger J R, Arendt G. 2000; HIV dementia: the role of the basal ganglia and dopaminergic systems, J Psychopharmacol. 14: 214–221
   Google Scholar
• Berger J R, Nath A. 1997; HIV dementia and the basal ganglia, Intervirology. 40: 122–131
   Google Scholar
• Biswas D K, Ahlers C M, Dezube B J, Pardee A B. 1994; Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression, Mol Med. 1: 31–43
   Google Scholar
• Bradford M M. 1976; Rapid and sensitive method for quantitation of microgram quantities of proteins utilizing principle of protein dye binding, Anal Biochem. 72: 248–254
   Google Scholar
• Cornford M E, Holden J K, Boyd M C, Berry K, Vinters H V. 1992; Neuropathology of the acquired immune deficiency syndrome (AIDS): report of 39 autopsies from Vancouver, British Columbia, Can J Neurol Sci. 19: 442–452
   Google Scholar
• Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, Muller J G, Pedersen V, Gsell W, Heeney J L, Gerlach M, Gosztonyi G, Riederer P, ter, Meulen V. 2001; Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs, Acta Neuropathol (Berl). 101: 85–91
   Google Scholar
• Dowlatshahi D, MacQueen G M, Wang J F, Young L T. 1998. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet. 352: 1754–1755. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Duman R S, Heninger G R, Nestler E J. 1997; A molecular and cellular theory of depression, Arch Gen Psychiatry. 54: 597–606
   Google Scholar
• Fibiger H C. 1984; The neurobiological substrates of depression in Parkinson's disease: a hypothesis, Can J Neurol Sci. 11: 105–107
   Google Scholar
• Gerlach M, Youdim M B, Riederer P. 1994. Is selegiline neuroprotective in Parkinson's disease?. J Neural Transm Suppl. 41: 177–188. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Gsell W, Lange K, Pfeuffer L, Heckers S, Heinsen H, Senitz D, Jellinger K, Ransmayr G, Wichart R, Vock R, Beckmann H, Riederer P. 1993; How to run a brain bank. A report from the Austro-German brain bank, J Neural Transm (Suppl). 39: 31–70
   Google Scholar
• Hyman C, Hofer M, Barde Y A, Juhasz M, Yancopoulos G D, Squinto S P, Lindsay R M. 1991; BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra, Nature. 350: 230–232
   Google Scholar
• Klimek V, Schenck J E, Han H, Stockmeier C A, Ordway G A. 2002; Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study, Biol Psychiatry. 52: 740–748
   Google Scholar
• Koutsilieri E, Scheller C, Sopper S, Ter, Meulen V, Riederer P. 2002a; Psychiatric complications in human immunodeficiency virus infection, J NeuroVirol. 8((Suppl 2))129–133
   Google Scholar
• Koutsilieri E, Sopper S, Scheller C, ter, Meulen V, Riederer P. 2002b; Involvement of dopamine in the progression of AIDS Dementia Complex, J Neural Transm. 109: 399–410
   Google Scholar
• Koutsilieri E, Sopper S, Scheller C, ter, Meulen V, Riederer P. 2002c; Parkinsonism in HIV dementia, J Neural Transm. 109: 767–775
   Google Scholar
• Kure K, Weidenheim K M, Lyman W D, Dickson D W. 1990; Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration, Acta Neuropathol. 80: 393–400
   Google Scholar
• Lopez O L, Smith G, Meltzer C C, Becker J T. 1999; Dopamine systems in human immunodeficiency virus-associated dementia, Neuropsychiatry Neuropsychol Behav Neurol. 12: 184–192
   Google Scholar
• Minghetti L, Nicolini A, Polazzi E, Creminon C, Maclouf J, Levi G. 1997; Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors, Glia. 19: 152–160. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Montminy M. 1997; Transcriptional regulation by cyclic AMP, Annu Rev Biochem. 66: 807–822
   Google Scholar
• Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser K F, Mattson M. 2000; Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia, J Psychopharmacol. 14: 222–227
   Google Scholar
• Navia B, Cho E, Petito C, et al, 1986; The AIDS dementia complex. II. Neuropathology, Annals of Neurology. 19: 525–535
   Google Scholar
• Nestler E J, Barrot M, Di, Leone R J, Eisch A J, Gold S J, Monteggia L M. 2002; Neurobiology of depression, Neuron. 34: 13–25
   Google Scholar
• Nuovo G, Alfieri M. 1996; AIDS dementia is associated with massive, activated HIV-1 infection and concomittant expression of several cytokines, Mol Med. 2: 358–366
   Google Scholar
• Patrizio M, Colucci M, Levi G. 2001; Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia cultures, J Neurochem. 77: 399–407
   Google Scholar
• Reyes M G, Faraldi F, Senseng C S, Flowers C, Fariello R. 1991; Nigral degeneration in acquired immune deficiency syndrome (AIDS), Acta Neuropathol (Berl). 82: 39–44
   Google Scholar
• Rottenberg D A, Moeller J R, Strother S C, Sidtis J J, Navia B A, Dhawan V, Ginos J Z, Price R W. 1987; The metabolic pathology of the AIDS dementia complex, Ann Neurol. 22: 700–706
   Google Scholar
• Sardar A, Czudek C, Reynolds G. 1996; Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS, Neuroreport. 7: 910–912
   Google Scholar
• Sauermann U, Krawczak M, Hunsmann G, Stahl-Hennig C. 1997; Identification of Mhc-Mamu-DQB1 allele combinations associated with rapid disease progression in rhesus macaques infected with simian immunodeficiency virus, AIDS. 11: 1196–1198
   Google Scholar
• Senogles S E, Amlaiky N, Berger J G, Caron M G. 1988; Biochemical properties of D1 and D2 dopamine receptors, Adv Exp Med Biol. 235: 33–41
   Google Scholar
• Sopper S, Koutsilieri E, Scheller C, Czub S, Riederer P, ter, Meulen V. 2002; Macaque animal model for HIV-induced neurological disease, J Neural Transm. 109: 747–766
   Google Scholar
• Sopper S, Nierwetberg D, Halbach A, Sauer U, Scheller C, Stahl-Hennig C, Matz-Rensing K, Schafer F, Schneider T, ter, Meulen V, Muller J G. 2003; Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys, Blood. 101: 1213–1219
   Google Scholar
• Suzumura A, Ito A, Yoshikawa M, Sawada M. 1999; Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS, Brain Res. 837: 203–212
   Google Scholar
• Treisman G, Fishman M, Schwartz J, Hutton H, Lyketsos C. 1998; Mood disorders in HIV infection, Depress Anxiety. 7: 178–187
   Google Scholar
• Tyor W R, Glass J D, Griffin J W, Becker P S, McArthur J C, Bezman L, Griffin D E. 1992; Cytokine expression in the brain during the acquired immunodeficiency syndrome, Ann Neurol. 31: 349–360
   Google Scholar
• Yamada S, Yamamoto M, Ozawa H, Riederer P, Saito T. 2003; Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder, J Neural Transm. 110: 671–680
   Google Scholar
• Yamamoto-Sasaki M, Ozawa H, Saito T, Rosler M, Riederer P. 1999; Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type, Brain Res. 824: 300–303
   Google Scholar
• Zafra F, Lindholm D, Castren E, Hartikka J, Thoenen H. 1992; Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes, J Neurosci. 12: 4793–4799
   Google Scholar
• Zauli G, Milani D, Mirandola P, Mazzoni M, Secchiero P, Miscia S, Capitani S. 2001; HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway, Faseb J. 15: 483–491
   Google Scholar
• Zauli G, Secchiero P, Rodella L, Gibellini D, Mirandola P, Mazzoni M, Milani D, Dowd D R, Capitani S, Vitale M. 2000; HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells, J Biol Chem. 275: 4159–4165
   Google Scholar